This inventor holds 2 USPTO granted patents. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: The Innovative Contributions of Junichi Yamashita
Introduction: Junichi Yamashita is a notable inventor based in Tokushima, Japan, recognized for his contributions to the field of pharmaceuticals. With a total of two patents to his name, Yamashita is dedicated to advancing medicinal chemistry and enhancing therapeutic options.
Latest Patents: Junichi Yamashita's recent patents focus on the preparation and compositions of 5-fluoropyrimidin-4-one derivatives. These compounds are represented by a specific formula, incorporating straight-chain or branched-chain alkyl groups with 4 to 18 carbon atoms, straight-chain or branched-chain alkenyl groups with 2 to 18 carbon atoms, alkylene oxido groups with 3 to 10 carbon atoms, as well as aryl or aralkyl groups. His first patent details the preparation of these derivatives, while the second patent focuses on compositions related to 5-fluoropyrimidin-4-one. Notably, these derivatives are highlighted for their potential application in anti-tumor compositions, suggesting significant implications for cancer treatment.
Career Highlights: Yamashita's professional journey is marked by his association with Taisho Pharmaceutical Co., Ltd., where he plays an integral role in research and development. His work in the company emphasizes innovative solutions aimed at improving health outcomes and combating diseases through advanced pharmaceutical formulations.
Collaborations: Throughout his career, Junichi Yamashita has collaborated with colleagues such as Mitugi Yasumoto and Ichiro Yamawaki. These partnerships have fostered an environment of creativity and shared knowledge, leading to advancements in the products developed within Taisho Pharmaceutical.
Conclusion: Junichi Yamashita's contributions to the field of pharmacology, demonstrated through his patents and collaborations, reflect his commitment to innovation and scientific advancement. His work continues to influence the development of effective therapeutic agents and showcases the importance of research-driven approaches in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
